key: cord-0834023-xl0z4bna
authors: Martel, Rachel A.; Shaw, Jacquelyn; Blakemore, Jennifer K.
title: TRENDS IN FSH LEVELS AND CYCLE COMPLETION RATES IN WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY (ART) BEFORE AND DURING THE COVID-19 PANDEMIC
date: 2021-07-31
journal: Fertility and Sterility
DOI: 10.1016/j.fertnstert.2021.05.050
sha: ab79b4fd3426960ad74a78d18a1ae25231d5fcdb
doc_id: 834023
cord_uid: xl0z4bna

nan

again without significance (ABD 40.8% (20/49) vs. LSC 51.5% (34/66), p¼0.78). Rates of biochemical, ectopic and spontaneous abortion were overall low in this cohort and not significantly different (Table 1) .

CONCLUSIONS: Minimally invasive approaches to myomectomies have known surgical outcome advantages, and we show that outcomes of laparoscopic approach are no worse than those following abdominal cases. Our data suggests superiority of laparoscopy, however more cases need to be collected to establish statistical significance.

FINANCIAL SUPPORT: None BACKGROUND: SARS-CoV-2 causes a robust inflammatory response 1 , with some inflammatory mediators elevated even in the asymptomatic population 2 . Follicle stimulating hormone (FSH) levels have been shown to be positively correlated with markers of inflammation 3 . Additionally, the SARS-CoV-2 pandemic has been associated with significant psychological stress worldwide 4, 5 . Increased levels of daily stress have been shown to be positively associated with FSH levels and increased risk for anovulation. 6 OBJECTIVE: To assess if the SARS-CoV-2 2019 pandemic affected FSH levels, cycle no-starts, or cycle cancellations in women undergoing ART.

MATERIALS AND METHODS: We performed a retrospective cohort study of all patients who underwent oocyte cryopreservation, In Vitro Fertilization (IVF), oocyte donation, and embryo banking from 4/2020-9/2020 (DURING SARS CoV-2, ''DUR'') compared to 4/2019-9/2019 (PRE SARS CoV-2, ''PRE'') at a single urban, academic fertility center. Primary outcome was FSH level. Notably, the laboratory assay method changed between 2019 and 2020, therefore, FSH levels were categorized into quartiles using assay manufacturer standards to allow for comparison across platforms. Secondary outcomes included cycle no-starts and cycle cancellation. Statistical analyses were performed using Kolmogorov-Smirnoff, Mann Whitney U, Fisher's Exact, and Pearson chi-squared tests where appropriate with p<0.05 considered statistically significant.

RESULTS: 2129 patients were included in the analysis, with 997 PRE and 1132 DUR. The mean patient age was similar in each cohort at 36.9 years (p¼0.47). The mean FSH level was 6.9 mIU/mL PRE (range 0.10-25.9) and 8.5 mIU/mL DUR (range 0.10-133.1). However, as noted, assay platforms differed between years. A comparison of FSH level by quartile per platform showed a significantly higher portion of patients in the upper two quartiles DUR compared to PRE SARS-CoV-2 (Table 1 ). There was no statistical difference in rates of clinically elevated FSH at cycle start (''no start'') between groups (5.6% PRE vs 7.0% DUR, p¼0.21). Similarly, the rates of cycle no-start for all indications were similar between cohorts (10.7% PRE vs. 11.1% DUR, p¼0.78). Finally, rates of cycle cancelation were also not different between groups (7.6% PRE vs. 5.7% DUR, p¼0.08).

CONCLUSIONS: SARS-CoV-2 is a proinflammatory state and is stressinducing. While patients undergoing ART during the pandemic do not seem to experience cycle cancelation or no-start at increased rates, there is a general trend of increased FSH levels at cycle start compared to prepandemic. Further research is needed to determine the impact on ART cycle outcomes.

FINANCIAL SUPPORT: No financial support to disclose. BACKGROUND: The purpose of this study is to evaluate the potential scope of benefit from routine diabetes screening with glycosylated hemoglobin (HbA1C) for all patients presenting with infertility.

OBJECTIVE: A hyperglycemic metabolic state can have a negative impact during the peri-conception period. Currently, it is recommended that only women with preexisting risk factors for hyperglycemia (i.e. PCOS and obesity) seeking fertility treatment undergo diabetes screening. The purpose of this study is to evaluate the potential scope of benefit from routine diabetes screening with glycosylated hemoglobin (HbA1C) for all patients presenting with infertility.

MATERIALS AND METHODS: Consecutive new patient visits for infertility were identified retrospectively and analyzed from December 2018 to January 2020. All new patients underwent diabetes screening with HbA1C during this time period at the time of their initial visits regardless of prior history or diagnosis. HbA1C values were stratified according to the American Diabetes Association: Normal <5.7%, Pre-diabetes 5.7-6.4%, Diabetes

The trinity of COVID-19: immunity, inflammation and intervention

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Role of inflammation and oxidative stress in the etiology of primary ovarian insufficiency

Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China

Perceived stress, reproductive hormones, and ovulatory function: a prospective cohort study. Epidemiology